Psoriasis and COVID-19: a multifactorial consideration

J Dermatolog Treat. 2022 Mar;33(2):1174. doi: 10.1080/09546634.2020.1782818. Epub 2020 Jun 22.

Authors

Jeffrey M Cohen¹, Lourdes M Perez-Chada², Dimitri De Kouchkovsky¹, Jeff R Gehlhausen¹

Affiliations

¹ Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Humans
Psoriasis* / drug therapy
SARS-CoV-2

Grants and funding

T32 GM007205/GM/NIGMS NIH HHS/United States